Stem cells aim to reverse frailty in the elderly
Disease control
Not yet recruiting
This early-stage trial tests a new stem cell treatment called HeXell-2020 in 12 elderly people with mild to moderate frailty. The treatment uses donated umbilical cord stem cells given through an IV. The main goal is to check safety and find the best dose, not yet to prove it wor…
Phase: PHASE1 • Sponsor: Hexun Biosciences Co., LTD. • Aim: Disease control
Last updated Jun 26, 2026 14:11 UTC